/

Dyne Therapeutics

Developing therapeutics for genetically driven neuromuscular diseases.

BiotechnologyPharmaceuticals dyne-tx.com ↗

Company facts

Founded: 2017
Employees: 258
Headquarters: United States
Type: Public
Listed: NASDAQ: DYN